Finance

Lists
Why is NXTC down ७.६९%?
Dive Deeper
NXTC:NASDAQ
NextCure Inc
US$ ५.७६
-७.६९%
(-०.४८) 1D
अक्टोबर १९, १२:४९:०८ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NXTC...
Open
US$ ६.१६
High
US$ ६.४६
Low
US$ ५.५८
Mkt. cap
२.६४ करोड
Avg. vol.
९२.३२ हजार
Volume
४१.५४ हजार
52-wk high
US$ १५.७४
52-wk low
US$ १.५५
EPS
-US$ १०.२७
Beta
१.३३
Shares outstanding
४५.७७ लाख
No. of employees
४०
Open
US$ ६.१६
High
US$ ६.४६
Low
US$ ५.५८
Mkt. cap
२.६४ करोड
Avg. vol.
९२.३२ हजार
Volume
४१.५४ हजार
52-wk high
US$ १५.७४
52-wk low
US$ १.५५
EPS
-US$ १०.२७
Beta
१.३३
Shares outstanding
४५.७७ लाख
No. of employees
४०
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
४ घण्टा पहिले
Technical Reactions to NXTC Trends in Macro Strategies
About NextCure Inc
CEO-
Employees४०
Founded२०१५
Headquarters-
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to NXTC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NXTC in the last 3 months
Highest
Current US$ ५.७६
US$ २०.०० (+२४७.२२%)
Average
US$ २०.०० (+२४७.२२%)
Lowest
US$ २०.०० (+२४७.२२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
US$ २०.००
+२४७.२%
08/13/2026
Edward Tenthoff
Piper Sandler
Buy
Maintained
US$ १५.००
+१६०.४%
06/10/2026
Christopher Liu
Lucid Capital
Buy
Maintained
US$ २५.००
+३३४%
06/02/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Upgraded
US$ १८.००
+२१२.५%
11/07/2025
Last report
२०२६ अगस्ट ६
Fiscal period
Q2 2026
-US$ १.८५ / -US$ १.९२
+३.८५%beat
Revenue / Est. (USD)
- / ०.००
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
६१.३६ लाख
६८.०० लाख
६८.३४ लाख
७४.२५ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२८.०९ लाख
२९.५७ लाख
३२.७१ लाख
२५.९२ लाख
Operating expense
८९.४५ लाख
९७.५७ लाख
१.०१ करोड
१.०० करोड
Total operating expenses
८९.४५ लाख
९७.५७ लाख
१.०१ करोड
१.०० करोड
Operating income
-८९.४५ लाख
-९७.५७ लाख
-१.०१ करोड
-१.०० करोड
Other non operating income
-
-
-
-
EBT including unusual items
-८६.२४ लाख
-९४.३६ लाख
-९७.९६ लाख
-१.४९ करोड
EBT excluding unusual items
-८६.२४ लाख
-९४.३६ लाख
-९७.९६ लाख
-९८.१५ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-८६.२४ लाख
-९४.३६ लाख
-९७.९६ लाख
-१.४९ करोड
Net profit margin
-
-
-
-
Earnings per share
-३.२२
-०.८१
-१.८७
-१.८५
Interest and investment income
३.२१ लाख
३.२१ लाख
३.०९ लाख
२.०२ लाख
Interest expense
-
-
-
-
Net interest expenses
३.२१ लाख
३.२१ लाख
३.०९ लाख
२.०२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-८४.१२ लाख
-९३.९२ लाख
-९८.२२ लाख
-९७.४५ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू